Company: GMRE
Filing Date: 2025-03-31
Form Type: DEF 14A
Source: 0001104659-25-029872
Chunk: 27

Company: Global Medical REIT Inc.
Filing Date: 2025-03-31
Form: DEF 14A
Chunk 27
---
 to certain conditions. |

| (13) | Includes 7,830 shares of common stock and 34,692 vested LTIP Units convertible    
 into shares of common stock on a one-for-one basis subject to certain conditions. |

| (14) | Includes 34,692 vested LTIP Units convertible into shares of common stock 
 on a one-for-one basis subject to certain conditions.                     |

| (15) | Includes 28,747 vested LTIP Units convertible into shares of common stock 
 on a one-for-one basis subject to certain conditions.                     |

19 CORPORATE GOVERNANCE Board and Annual Stockholders’ Meetings The Board of Directors meets regularly to review significant developments affecting us and to act on matters requiring its approval. The Board held 13 meetings in 2024. All the Company’s directors serving at the time of the 2024 annual meeting attended the 2024 annual meeting. Our corporate governance guidelines provide that all Board members are expected to attend our annual meeting of stockholders. In 2024 no director attended fewer than 75% of the aggregate total number of meetings of the Board of Directors or of the committees on which they served during 2024. Committees of the Board of Directors The Board of Directors has established an Audit Committee, a Nominating and Corporate Governance Committee, a Compensation Committee and an Environmental, Social and Governance Committee (the “ESG Committee”). A current copy of each committee’s charter is available on our website at www.globalmedicalreit.com. Audit Committee .Beginning on January 1, 2025, our Audit Committee consists of four of our independent directors, Ms. Wittman, Ms. Crowley, Mr. Cole and Dr. Cypher. Ms. Wittman has been appointed to serve as the chair of the Audit Committee. Each of these members has been determined to be “independent” within the meaning of the applicable standards of the NYSE and Rule 10A-3 of the Exchange Act. In addition, each of these members meets the financial literacy requirements for audit committee membership under applicable standards of the NYSE and the rules and regulations of the SEC. Our Board has determined that Ms. Wittman is an “audit committee financial expert” as such term is defined in Item 407(d)(5)(ii) and (iii) of Regulation S-K. No member of the Audit Committee serves on the audit committee of more than three public companies. The Audit Committee held six meetings in 2024. The primary purpose of the Audit Committee is to assist